Stoke Therapeutics, Inc. STOK Business Segments
| FY'25 | ||
|---|---|---|
| Revenue by Product | ||
| Global Development Activity | $17.49M— | |
| IP License | $150.78M— | |
| License | $11.5M-60.9% | |
| Service | $4.6M-36.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Stoke Therapeutics, Inc. break its business down?
- Stoke Therapeutics, Inc. (STOK) reports revenue by product across 4 parts — Global Development Activity, IP License, License and Service. Each is extracted from the segment footnotes and tracked over time.
- Where does Stoke Therapeutics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Stoke Therapeutics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.